Clinical trial
International LEMTRADA Pregnancy Exposure Cohort in Multiple Sclerosis
NCT03774914 is registered in ClinicalTrials.gov with Genzyme, a Sanofi Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- International LEMTRADA Pregnancy Exposure Cohort in Multiple Sclerosis
- Lead sponsor
- Genzyme, a Sanofi Company
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 1, 2015
- Completion date
- November 22, 2021
- Enrollment
- 42 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.